With custom chips and billions in investment, this high-stakes infrastructure battle could shape the future of AI.

Google DeepMind has reportedly restricted on sharing research will stifle AI innovation, warns the CEO of Iris.ai, one of ...

Sissie Hsaio, the Google exec who oversaw the launch of the company’s AI chatbot, is stepping down as head of the Gemini app, ...

Google reshuffles AI leadership with Sissie Hsiao stepping down and Josh Woodward stepping in to drive Gemini's evolution.

Google DeepMind on Wednesday published an exhaustive paper on its safety approach to AGI, roughly defined as AI that can ...

Newly appointed AgiBot chief scientist Luo Jianlan, who previously worked at Google, spearheads the advanced AI research ...

Qualcomm has acquired VinAI’s generative AI division to strengthen its AI capabilities. This strategic move aims to ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...